Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia

Sumeet Subherwal; Kevin J. Anstrom; William S. Jones; Michael G. Felker; Sanjay Misra; Michael S. Conte; William R. Hiatt; Manesh R. Patel

doi:10.1016/j.ahj.2012.07.002

Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia

Sumeet Subherwal, Kevin J. Anstrom, William S. Jones, Michael G. Felker, Sanjay Misra, Michael S. Conte, William R. Hiatt, Manesh R. Patel

Radiology

Research output: Contribution to journal › Editorial › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	277-284
Number of pages	8
Journal	American heart journal
Volume	164
Issue number	3
DOIs	https://doi.org/10.1016/j.ahj.2012.07.002
State	Published - Sep 2012

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ahj.2012.07.002

Cite this

@article{bbd43f9b1087467f9eaaa7ae9f0da2b2,

title = "Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia",

author = "Sumeet Subherwal and Anstrom, {Kevin J.} and Jones, {William S.} and Felker, {Michael G.} and Sanjay Misra and Conte, {Michael S.} and Hiatt, {William R.} and Patel, {Manesh R.}",

note = "Funding Information: William R. Hiatt: Research grant support from the following sponsors involved in clinical trials in PAD: Aastrom, AstraZeneca, DNAVEC, GSK, Medrad Possis, Pleuristem. Funding Information: Sunjay Misra: Consulting fees from Flexstent and Arteriocyte (<$5,000), and research grant support from NHLBI. ",

year = "2012",

month = sep,

doi = "10.1016/j.ahj.2012.07.002",

language = "English (US)",

volume = "164",

pages = "277--284",

journal = "American heart journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia

AU - Subherwal, Sumeet

AU - Anstrom, Kevin J.

AU - Jones, William S.

AU - Felker, Michael G.

AU - Misra, Sanjay

AU - Conte, Michael S.

AU - Hiatt, William R.

AU - Patel, Manesh R.

N1 - Funding Information: William R. Hiatt: Research grant support from the following sponsors involved in clinical trials in PAD: Aastrom, AstraZeneca, DNAVEC, GSK, Medrad Possis, Pleuristem. Funding Information: Sunjay Misra: Consulting fees from Flexstent and Arteriocyte (<$5,000), and research grant support from NHLBI.

PY - 2012/9

Y1 - 2012/9

UR - http://www.scopus.com/inward/record.url?scp=84866321753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866321753&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2012.07.002

DO - 10.1016/j.ahj.2012.07.002

M3 - Editorial

C2 - 22980292

AN - SCOPUS:84866321753

SN - 0002-8703

VL - 164

SP - 277

EP - 284

JO - American heart journal

JF - American heart journal

IS - 3

ER -

Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this